| Net Cash Provided by (Used in) Operating Activities |
-42.5K |
USD |
-12.4% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
107M |
shares |
+1.84% |
Q2 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-42.5K |
USD |
-786% |
Q3 2024 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.28K |
USD |
0% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
208K |
USD |
+35.4% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
208K |
USD |
+35.4% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
3.32M |
USD |
+3.39% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
12.3K |
USD |
+6.98% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |